GuruTrack
CVS

CVS

CVS HEALTH CORP

Data as of 2026 Q1 (03-31) · 13F snapshot

Summary
CVS HEALTH CORP (CVS) is held by 12 tracked hedge-fund managers, a combined reported value of ~$1.59B; the largest are Ken Griffin, Warren Buffett, Ken Griffin. This quarter: 1 new, 1 added, 3 trimmed, 1 closed. 20 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · HighThis quarter · Cooling
Gurus holding12
Congress trades20
Price$107.74vs quarter-end+50.01%
Sectors1
This quarter's moves
New1
Added1
Trimmed / sold4
Top holderKen Griffin
Value $247.76M0.3% of portfolio5,301,9162012 Q2
Value $176.16M— of portfolio2,452,8002026 Q1
Value $159.33M— of portfolio2,218,4002026 Q1
Dan LoebNew large stake
Value $99.04M1.3% of portfolio1,575,0002024 Q3
Value $69.52M— of portfolio968,0002026 Q1
Value $43.83M— of portfolio525,3002021 Q2
Value $43.31M— of portfolio603,1002026 Q1
Value $8.50M— of portfolio118,4002026 Q1
Value $5.15M— of portfolio71,7002026 Q1
Michael BurryNew large stake
Value $5.13M5.4% of portfolio65,0002023 Q4

Insider Trading

Officers · directors · Form 4
  • James David Clark

    SVP, Cont & Chief Acct Officer

    Sell$41.3K
    454 @ $90.98Traded 2026-06-26Filed 2026-06-29
  • Brian Newman

    EVP, Chief Financial Officer

    Sell$225.4K
    2,478 @ $90.98Traded 2026-05-31Filed 2026-06-01
  • Amy Compton-Phillips

    EVP, Chief Medical Officer

    Sell$693.1K
    7,618 @ $90.98Traded 2026-05-31Filed 2026-06-01
  • Fernando Aguirre

    Director

    Sell$146.1K
    1,563 @ $93.50Traded 2026-05-20Filed 2026-05-22
  • Fernando Aguirre

    Director

    Sell$2.85M
    30,437 @ $93.78Traded 2026-05-20Filed 2026-05-22
  • Larry Robbins

    Director

    Sell$74.56M
    797,628 @ $93.48Traded 2026-05-19Filed 2026-05-21
  • Larry Robbins

    Director

    Sell$14.4K
    151 @ $95.18Traded 2026-05-19Filed 2026-05-21
  • Larry Robbins

    Director

    Sell$187.33M
    1,983,387 @ $94.45Traded 2026-05-19Filed 2026-05-21
  • Larry Robbins

    Director

    Sell$77.0K
    800 @ $96.28Traded 2026-05-19Filed 2026-05-21
  • Larry Robbins

    Director

    Sell$6.40M
    66,881 @ $95.67Traded 2026-05-19Filed 2026-05-21
  • Larry Robbins

    Director

    Sell$14.48M
    152,691 @ $94.81Traded 2026-05-19Filed 2026-05-21
  • Larry Robbins

    Director

    Sell$35.27M
    378,000 @ $58.29Traded 2026-05-19Filed 2026-05-21
  • Larry Robbins

    Director

    Sell$34.62M
    370,462 @ $93.45Traded 2026-05-19Filed 2026-05-21
  • Fernando Aguirre

    Director

    Buy$151.8K
    1,563 @ $97.15Traded 2026-05-14Filed 2026-05-15
  • Larry Robbins

    Director

    Buy$187.5K
    1,930 @ $0.00Traded 2026-05-14Filed 2026-05-15
  • Michael F Mahoney

    Director

    Buy$168.8K
    1,737 @ $0.00Traded 2026-05-14Filed 2026-05-15
  • David C Brown II

    Director

    Buy$150.0K
    1,544 @ $97.15Traded 2026-05-14Filed 2026-05-15
  • Anne A. Finucane

    Director

    Buy$150.0K
    1,544 @ $0.00Traded 2026-05-14Filed 2026-05-15
  • DECOUDREAUX ALECIA A

    Director

    Buy$140.6K
    1,448 @ $0.00Traded 2026-05-14Filed 2026-05-15
  • Guy P Sansone

    Director

    Buy$140.6K
    1,447 @ $97.15Traded 2026-05-14Filed 2026-05-15
  • Leslie V Norwalk

    Director

    Buy$140.6K
    1,447 @ $97.15Traded 2026-05-14Filed 2026-05-15
  • Douglas H. Shulman

    Director

    Buy$140.6K
    1,448 @ $0.00Traded 2026-05-14Filed 2026-05-15
  • Scott J Kirby

    Director

    Buy$140.6K
    1,447 @ $97.15Traded 2026-05-14Filed 2026-05-15
  • Jeffrey R. Balser

    Director

    Buy$199.9K
    2,058 @ $97.15Traded 2026-05-14Filed 2026-05-15

Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.

Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.